비교리스트

 카트 문의
시장보고서
상품코드
1526289

세계의 헬스케어 유통 시장

Healthcare Distribution
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 417 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헬스케어 유통 세계 시장은 2030년까지 5조 7,000억 달러에 이를 전망

2023년에 2조 3,000억 달러로 추정되는 헬스케어 유통 세계 시장은 분석 기간인 2023-2030년에 CAGR 13.9%로 성장하여 2030년에는 5조 7,000억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 의약품 유통은 CAGR13.6%를 나타내고, 분석 기간 종료시에는 2조 3,000억 달러에 이를 것으로 예측됩니다. 바이오의약품 유통 부문의 성장률은 분석 기간중 CAGR 15.2%로 추정됩니다.

미국 시장은 8,047억 달러로 추정, 중국은 CAGR 16.2%로 성장 예측

미국의 헬스케어 유통시장은 2023년에 8,047억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023-2030년간 CAGR16.2%로 성장하여 2030년에는 시장 규모가 1조 달러에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 11.8%와 11.5%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 13.6%를 나타낼 전망입니다.

세계 헬스케어 유통 시장 - 주요 동향 및 촉진요인 정리

헬스케어 유통은 의료 공급망의 중요한 구성 요소로, 의약품, 의료기기, 의료용품이 제조업체에서 의료진과 환자에게 효율적으로 전달될 수 있도록 보장하는 역할을 합니다. 이 복잡한 네트워크에는 도매업체, 유통업체, 물류업체 등 다양한 이해관계자들이 의료 제품의 무결성과 가용성을 유지하기 위해 협력하고 있습니다. 헬스케어 유통 기업은 제품의 안전성과 유효성을 보장하기 위해 엄격한 규제와 표준을 준수하고, 제품의 보관, 취급, 운송을 책임지고 있습니다. 이 분야는 콜드체인 물류에서 온도에 민감한 의약품을 관리하는 것부터 병원 및 진료소에 생명을 구하는 의약품과 장비를 적시에 배송하는 것까지 다양한 활동을 포괄합니다. 효과적인 헬스케어 유통은 특히 응급 상황이나 공중보건 위기 상황에서 중요한 의약품의 지속적인 공급을 유지하는 데 필수적입니다.

헬스케어 유통 산업은 기술 및 물류 관리의 발전으로 크게 발전해 왔으며, RFID 및 블록체인과 같은 추적 기술의 통합으로 공급망의 투명성과 안전성이 향상되고 위조품이 시장에 유통될 위험이 감소했습니다. 디지털 헬스 플랫폼의 등장은 헬스케어 유통을 변화시켜 환자 직접 배송 모델을 가능하게 하고 헬스케어 제품에 대한 접근성을 확대했습니다. 이러한 기술 발전은 운영을 간소화할 뿐만 아니라 공급망에 대한 가시성과 관리를 향상시켜 의료 제공업체와 환자가 제품을 안전하고 예정대로 받을 수 있도록 돕습니다.

헬스케어 유통 시장의 성장은 의약품 수요 증가, 물류 기술 발전, 헬스케어 분야 확대 등 여러 가지 요인에 의해 이루어지고 있습니다. 만성질환 증가와 고령화로 인해 의약품 및 의료용품의 소비량이 증가하고 있으며, 효율적인 물류 네트워크가 필요합니다. 인공지능(AI)과 머신러닝을 통한 예측 분석과 같은 기술 발전은 공급망 운영을 최적화하고 수요 예측과 재고 관리를 강화하는 데 도움을 주고 있습니다. 또한, 신흥 시장의 의료 인프라가 확대되면서 늘어나는 의료 수요를 뒷받침할 수 있는 견고한 유통 네트워크의 필요성이 증가하고 있으며, 코로나19 팬데믹으로 인해 백신과 의약품을 신속하고 광범위하게 배포하는 것이 전 세계적인 우선순위가 되면서 탄력적인 헬스케어 유통 시스템의 중요성을 더욱 부각시켰습니다. 또한, 규정 준수를 위한 규제 동향과 개인 맞춤형 의료의 확대 추세는 특정 환자의 니즈를 충족시키기 위한 맞춤형 유통 솔루션의 필요성에 큰 동력이 되고 있습니다. 이러한 요인들이 종합적으로 헬스케어 유통 시장의 견조한 성장에 기여하고 있으며, 세계 헬스케어 생태계에서 헬스케어 유통이 중요한 역할을 할 수 있도록 하고 있습니다.

조사 대상 기업 예(총 61건)

  • Cardinal Health, Inc.
  • Epicor Software Corporation
  • Henry Schein, Inc.
  • FedEx Corporation
  • Imperial Logistics Group(Pty) Limited
  • HighJump Software, Inc.
  • CenTrak, Inc.
  • Biolog-id
  • Express Scripts Holding Company
  • AmerisourceBergen Corporation
  • Global Healthcare Exchange LLC(Ghx)
  • Alliance Healthcare
  • Cavalier Logistics
  • Intalere
  • Hvantage Technologies Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.08.09

Global Healthcare Distribution Market to Reach US$5.7 Trillion by 2030

The global market for Healthcare Distribution estimated at US$2.3 Trillion in the year 2023, is expected to reach US$5.7 Trillion by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$2.3 Trillion by the end of the analysis period. Growth in the Biopharmaceutical Distribution segment is estimated at 15.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$804.7 Billion While China is Forecast to Grow at 16.2% CAGR

The Healthcare Distribution market in the U.S. is estimated at US$804.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Trillion by the year 2030 trailing a CAGR of 16.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.8% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.6% CAGR.

Global Healthcare Distribution Market - Key Trends & Drivers Summarized

Healthcare distribution is a critical component of the medical supply chain, ensuring that pharmaceutical products, medical devices, and healthcare supplies are efficiently delivered from manufacturers to healthcare providers and patients. This complex network involves various stakeholders, including wholesalers, distributors, and logistics providers, who coordinate to maintain the integrity and availability of medical products. Healthcare distribution companies are responsible for the storage, handling, and transportation of these products, adhering to stringent regulations and standards to ensure product safety and efficacy. The sector encompasses a wide range of activities, from managing temperature-sensitive medications in cold chain logistics to ensuring timely delivery of life-saving drugs and equipment to hospitals and clinics. Effective healthcare distribution is essential for maintaining the continuous supply of critical medical products, particularly during emergencies and public health crises.

The healthcare distribution industry has evolved significantly with advancements in technology and logistics management. The integration of track-and-trace technologies, such as RFID and blockchain, has improved the transparency and security of the supply chain, reducing the risk of counterfeit products entering the market. The rise of e-commerce and digital health platforms has also transformed healthcare distribution, enabling direct-to-patient delivery models and expanding access to healthcare products. These technological advancements not only streamline operations but also provide better visibility and control over the supply chain, ensuring that healthcare providers and patients receive their products safely and on time.

The growth in the healthcare distribution market is driven by several factors, including increasing demand for pharmaceutical products, advancements in logistics technology, and the expansion of the healthcare sector. The rising prevalence of chronic diseases and an aging population have led to higher consumption of medications and medical supplies, necessitating efficient distribution networks. Technological advancements, such as the implementation of artificial intelligence (AI) and machine learning in predictive analytics, have optimized supply chain operations, enhancing demand forecasting and inventory management. Additionally, the expansion of healthcare infrastructure in emerging markets has increased the need for robust distribution networks to support growing medical needs. The COVID-19 pandemic further underscored the importance of resilient healthcare distribution systems, as the rapid and widespread distribution of vaccines and medical supplies became a global priority. Moreover, regulatory pressures to ensure compliance and the growing trend of personalized medicine are also significant drivers, requiring tailored distribution solutions to meet specific patient needs. These factors collectively contribute to the robust expansion of the healthcare distribution market, ensuring its critical role in the global healthcare ecosystem.

Select Competitors (Total 61 Featured) -

  • Cardinal Health, Inc.
  • Epicor Software Corporation
  • Henry Schein, Inc.
  • FedEx Corporation
  • Imperial Logistics Group (Pty) Limited
  • HighJump Software, Inc.
  • CenTrak, Inc.
  • Biolog-id
  • Express Scripts Holding Company
  • AmerisourceBergen Corporation
  • Global Healthcare Exchange LLC (Ghx)
  • Alliance Healthcare
  • Cavalier Logistics
  • Intalere
  • Hvantage Technologies Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Healthcare Distribution - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Substandard Drugs, an Urgent Challenge in the Supply Chain that Begs to be Addressed
    • Pharmaceutical Thefts & Counterfeiting, A Persistent Challenge in Distribution That Eludes Resolution
    • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
    • Storming Into the Spotlight Is the Use of Blockchain in Fighting Counterfeiting of Drugs
    • Serialization Emerges as an Another Weapon in the Arsenal to Battle Counterfeiting
    • Rising Healthcare Costs Drives Attractiveness of e-Pharmacies
    • Here's How Healthcare Costs Are Outstripping Global GDP: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Aging Population, Rising Prevalence of Chronic Diseases & Ensuing Demand for Drugs & Medical Equipment Rank as Major Drivers of Growth in the Market
    • Aging Population Steps-Up the Burden On Healthcare Systems Including Distribution: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Rising Prevalence of Chronic Diseases Amplifies Demand for Pharmaceutical Drugs & Distribution: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • Robust Demand for Pharmaceutical Drugs Drives Growth in the Market
    • Pharmaceutical Contract Manufacturing, a Barometer of the Growing Demand & Production of Drugs
    • More Drugs Being Manufactured Means More Drugs in Distribution: Global Opportunity for Pharmaceutical Contract Manufacturing (In US$ Billion) for Years 2020, 2022, 2024, and 2026
    • Artificial Intelligence to Revolutionize Pharmaceutical Retailing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Biopharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other End Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Healthcare Distribution Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Healthcare Distribution by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Healthcare Distribution by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제